BH
Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
---|---|---|---|---|---|---|---|
CXCL-8/IL8 Produced by Diffuse Large B-cell Lymphomas Recruits Neutrophils Expressing a Proliferation-Inducing Ligand APRIL | Cancer Research | 2017 | 457 | 1 | |||
Revisiting IL-6 antagonism in multiple myeloma | Critical reviews in oncology/hematology | 2016 | 429 | 0 | |||
Myelopoiesis dysregulation associated to sustained APRIL production in multiple myeloma-infiltrated bone marrow | Leukemia | 2015 | 575 | 333 | |||
Autocrine amplification of immature myeloid cells by IL-6 in multiple myeloma-infiltrated bone marrow | Leukemia | 2015 | 518 | 427 | |||
Selective APRIL blockade delays systemic lupus erythematosus in mouse | PloS one | 2012 | 545 | 251 | |||
Absence of up-regulation for a proliferation-inducing ligand in Sjögren's sialadenitis lesions | Rheumatology | 2011 | 617 | 1 | |||
Production of the plasma-cell survival factor a proliferation-inducing ligand (APRIL) peaks in myeloid precursor cells from human bone marrow | Blood | 2011 | 632 | 1 | |||
Comment on "Cutting edge: FcR-like 6 is an MHC class II receptor" | The Journal of immunology | 2010 | 528 | 0 | |||
CD56bright NK cells after hematopoietic stem cell transplantation are activated mature NK cells that expand in patients with low numbers of T cells | European Journal of Immunology | 2010 | 598 | 0 | |||
Tumors that look for their springtime in APRIL | Critical reviews in oncology/hematology | 2009 | 601 | 0 | |||
Comment on "Dendritic cells and monocyte/macrophages that create the IL-6/APRIL-rich lymph node microenvironment where plasmablasts mature" | The Journal of immunology | 2009 | 481 | 0 | |||
In situ detection of APRIL-rich niches for plasma-cell survival and their contribution to B-cell lymphoma development | Histology and histopathology | 2009 | 499 | 0 | |||
Lymph node tumor metastases: more susceptible than primary tumors to CD8(+) T-cell immune destruction | Trends in immunology | 2009 | 502 | 0 | |||
Synovial tissues concentrate secreted APRIL | Arthritis research & therapy | 2009 | 586 | 339 | |||
Heparan sulfate proteoglycans, Fc receptors, and DC suppression | Blood | 2008 | 524 | 0 | |||
Role of the tumour necrosis family ligand APRIL in solid tumour development: Retrospective studies in bladder, ovarian and head and neck carcinomas | European journal of cancer | 2008 | 537 | 0 | |||
Direct presentation of a melanocyte-associated antigen in peripheral lymph nodes induces cytotoxic CD8+ T cells | Cancer research | 2008 | 561 | 0 | |||
APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cells | Blood | 2008 | 618 | 0 | |||
Reconstitution of the immune system after hematopoietic stem cell transplantation in humans | Seminars in immunopathology | 2008 | 511 | 387 | |||
APRIL secreted by neutrophils binds to heparan sulfate proteoglycans to create plasma cell niches in human mucosa | The Journal of clinical investigation | 2008 | 586 | 585 | |||
Role of the tumor necrosis factor ligand APRIL in Hodgkin's lymphoma: a retrospective study including 107 cases | Experimental hematology | 2008 | 553 | 0 | |||
Neutrophil-derived APRIL concentrated in tumor lesions by proteoglycans correlates with human B-cell lymphoma aggressiveness | Blood | 2007 | 126 | 156 | |||
Activating CD94:NKG2C and inhibitory CD94:NKG2A receptors are expressed by distinct subsets of committed CD8+ TCR alphabeta lymphocytes | European Journal of Immunology | 2004 | 181 | 150 |